The miR-BART5-5p molecule directly targets PIAS3 and enhances the expression of PD-L1 through the regulation of the miR-BART5/PIAS3/pSTAT3/PD-L1 axis in EBV-associated gastric carcinomas. The gene discussed is PIAS3; the disease is gastric carcinoma.